These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6402675)

  • 1. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 3. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
    Retsas S; Thomas C; Hobbs JR
    Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
    Palangie T; Jouve M; Giralt E; Bretaudeau B; Pouillart P
    Bull Cancer; 1983; 70(5):437-8. PubMed ID: 6582941
    [No Abstract]   [Full Text] [Related]  

  • 7. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
    Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
    J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma.
    MacKie RM; Gaukroger JM; Wilson L; Gold J
    Cancer Treat Rep; 1984 Sep; 68(9):1185-8. PubMed ID: 6478453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of vindesine in patients with malignant melanoma.
    Camacho FJ; Young CW; Wittes RE
    Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of vindesine infusion in visceral metastatic malignant melanoma.
    Wagstaff J; Anderson HA; Shiu W; Thatcher N
    Cancer Treat Rep; 1983 Sep; 67(9):839-40. PubMed ID: 6883362
    [No Abstract]   [Full Text] [Related]  

  • 11. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic melanoma. The latest treatment options.
    Gale D
    Adv Nurse Pract; 1998 May; 6(5):42-6. PubMed ID: 9633289
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma.
    Olver IN; Byrne MJ; Walpole E; Vorobiof D; Jacobs C; Maart K; Hewitt S; McAdam G; Pouget JC; Pinel MC
    Eur J Cancer; 2007 Aug; 43(12):1829-32. PubMed ID: 17631996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update results of vindesine as a single agent in the therapy of advanced malignant melanoma.
    Retsas S; Peat I; Ashford R; Coe M; Maher J; Drury A; Hanham IW; Phillips RH; Newton KA; Westbury G
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():87-90. PubMed ID: 7438128
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicentre phase II trial of vindesine in malignant melanoma.
    Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 18. EORTC phase II trial of vindesine in advanced melanoma.
    Rümke P; Everall JD; Mulder JH; Rozencweig M; Czarnetzki B; Thomas D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1173-4. PubMed ID: 6684562
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy in metastatic melanoma - still useful or out of date?
    Ugurel S
    Onkologie; 2011; 34(4):159-60. PubMed ID: 21447971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.